Janus Kinase Inhibitors [MoA] - N0000190857

Pharmacologic Class Information

Pharmacologic Code N0000190857
Pharmacologic Name Janus Kinase Inhibitors
Pharmacologic Uses
  • Janus kinase (JAK) inhibitor
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Janus Kinase Inhibitors

The following table contains 14 products whose active ingredient are classified under the same pharmacologic class Janus Kinase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0002-4182Olumiant Non-Proprietary Name: BaricitinibTablet, Film CoatedOralEli Lilly And CompanyACTIVE
0002-4479Olumiant Non-Proprietary Name: BaricitinibTablet, Film CoatedOralEli Lilly And CompanyACTIVE
0002-4732Olumiant Non-Proprietary Name: BaricitinibTablet, Film CoatedOralEli Lilly And CompanyACTIVE
0002-6885Baricitinib Non-Proprietary Name: BaricitinibTablet, Film CoatedOralEli Lilly And CompanyACTIVE
0069-0501Xeljanz XRNon-Proprietary Name: TofacitinibTablet, Film Coated, Extended ReleaseOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0502Xeljanz XRNon-Proprietary Name: TofacitinibTablet, Film Coated, Extended ReleaseOralPfizer Laboratories Div Pfizer IncACTIVE
0069-1001Xeljanz Non-Proprietary Name: TofacitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-1002Xeljanz Non-Proprietary Name: TofacitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-1029Xeljanz Non-Proprietary Name: TofacitinibSolutionOralPfizer Laboratories Div Pfizer IncACTIVE
50881-007Opzelura Non-Proprietary Name: RuxolitinibCreamTopicalIncyte CorporationACTIVE
63539-012Xeljanz Non-Proprietary Name: TofacitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-016Xeljanz Non-Proprietary Name: TofacitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-501Xeljanz XRNon-Proprietary Name: TofacitinibTablet, Extended ReleaseOralU.s. PharmaceuticalsACTIVE
63539-502Xeljanz XRNon-Proprietary Name: TofacitinibTablet, Extended ReleaseOralU.s. PharmaceuticalsACTIVE